Omada Health, Inc. Common Stock (OMDA) Stock Forecast & Price Target
Omada Health, Inc. Common Stock · NASDAQ
$20.58+0.05 (+0.24%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering Omada Health, Inc. Common Stock, 10 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $18.00 to $30.00, a moderate spread. The average target of $24.33 sits 18% above the current $20.58. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 9 to 10 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.08 next quarter toward $0.47 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Moderate Buy
Strong Buy00%
Buy1083%
Hold217%
Sell00%
Strong Sell00%
Based on 12 analysts giving stock ratings to Omada Health, Inc. Common Stock.
As of Jul, 10 of 12 firms rate OMDA a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
OMDA EPS & revenue forecast
EPS · NEXT QUARTER
$0.08
Range $0.07 – $0.09 · 5 analysts · +179% YoY
Next period, 5 analysts expect Omada Health, Inc. Common Stock to earn $0.08 a share (range $0.07 – $0.09), versus $0.03 a year earlier. Full-year consensus is $0.31, growing to $0.47 the year after.
REVENUE · NEXT QUARTER
$82.9M
Range $81.6M – $86.1M · 5 analysts · +22% YoY
Revenue is expected to reach $82.9M (range $81.6M – $86.1M), +21.9% year-over-year. Full-year consensus is $328.0M, rising to $392.2M next year.
Top analysts covering Omada Health, Inc. Common Stock
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OMDA.
#1
Constantine Davides
JMP Securities · Rank #225
Buy
$21.00+2.0% to target
Overall win rate
34%
+ Follow
#2
Ryan MacDonald
Needham · Rank #386
Buy
$28.00+36.1% to target
Overall win rate
17%
+ Follow
#3
Saket Kalia
Barclays
Buy
$20.00-2.8% to target
Coverage
—
+ Follow
#4
Richard Close
Canaccord Genuity
Buy
$28.00+36.1% to target
Coverage
—
+ Follow
#5
David Roman
Goldman Sachs
Buy
$25.00+21.5% to target
Coverage
—
+ Follow
OMDA stock forecast FAQ
What is OMDA's average 12-month price target?+
The 12 analysts with a live target average $24.33 for Omada Health, Inc. Common Stock over the next 12 months, ranging from a $30.00 high to a $18.00 low.
Is OMDA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 12 analyst ratings, 10 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for OMDA?+
The Street-high target is $30.00 (BTIG), and the Street-low is $18.00 (Wells Fargo). The average of all 12 active targets is $24.33.
How many Wall Street analysts cover OMDA?+
12 analysts have an active rating on Omada Health, Inc. Common Stock, and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering OMDA?+
Among analysts who currently cover OMDA, Constantine Davides of JMP Securities has the strongest overall Quantellect track record (Rank #225). Their current call is Buy with a $21.00 target.
What is Omada Health, Inc. Common Stock's projected EPS for next quarter?+
The consensus estimate is $0.08 per share (range $0.07 – $0.09) across 5 analysts. Full-year EPS is projected at $0.31, rising to $0.47 the following year.
How much revenue is Omada Health, Inc. Common Stock expected to report next quarter?+
Consensus revenue is $82.9M (range $81.6M – $86.1M). Full-year revenue is projected at $328.0M, growing to $392.2M next year.
Have analysts been upgrading or downgrading OMDA lately?+
As of Jul, 10 of 12 firms rate OMDA a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OMDA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
